Strong multidisciplinary support and political commitment have helped Spain become one of
the countries most likely to eliminate hepatitis C. In this Comment, we set out six key …

Background Underlying immunodeficiency is associated with severe COVID-19, but the
prognosis of persons with human immunodeficiency virus (HIV)(PWH) with COVID-19 is …

Background Liver disease causes over two million deaths annually worldwide, comprising
approximately 4% of all global fatalities. We aimed to analyze liver disease-related mortality …

Abstract Objectives Hepatitis C virus (HCV) has been recognized as a sexually transmitted
infection (STI) in HIV-positive men who have sex with men (MSM), with an increased …

Background In 2015, hepatitis C treatment with direct-acting antivirals (DAAs) became free
and widespread in Spain, significantly reducing hepatitis C–related mortality. However …

Simple Summary Epidemiological data on viral hepatitis are essential to optimize screening
programs. For HCV, the Italian Health Ministry planned a cohort screening for those born in …

Background Hepatitis C virus (HCV) has high global prevalence and can lead to liver
complications and death. Access to direct-acting antivirals (DAAs) in Canada increased …

ABSTRACT Although Hepatitis C virus (HCV) infection can be cured with direct‐acting
antivirals (DAA), some cured patients face a serious risk of advanced liver damage and early …

Abstract Background and Aim Hepatocellular carcinoma (HCC) surveillance in low‐risk
patients (annual incidence< 1.5%) is not recommended per the American Association for the …

Introduction The risk of mortality in people with a history of injection drug use (PHID) is high,
as is the prevalence of hepatitis C virus (HCV) infection. Although direct‐acting antivirals …